vs

Side-by-side financial comparison of Arteris, Inc. (AIP) and ASSEMBLY BIOSCIENCES, INC. (ASMB). Click either name above to swap in a different company.

Arteris, Inc. is the larger business by last-quarter revenue ($20.1M vs $10.8M, roughly 1.9× ASSEMBLY BIOSCIENCES, INC.). Arteris, Inc. runs the higher net margin — -42.2% vs -85.2%, a 43.0% gap on every dollar of revenue. On growth, ASSEMBLY BIOSCIENCES, INC. posted the faster year-over-year revenue change (57.6% vs 30.0%). Arteris, Inc. produced more free cash flow last quarter ($3.0M vs $-15.2M).

Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP and system-on-chip (SoC) integration automation software that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace & defense markets. The company specializes in the development a...

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

AIP vs ASMB — Head-to-Head

Bigger by revenue
AIP
AIP
1.9× larger
AIP
$20.1M
$10.8M
ASMB
Growing faster (revenue YoY)
ASMB
ASMB
+27.6% gap
ASMB
57.6%
30.0%
AIP
Higher net margin
AIP
AIP
43.0% more per $
AIP
-42.2%
-85.2%
ASMB
More free cash flow
AIP
AIP
$18.2M more FCF
AIP
$3.0M
$-15.2M
ASMB

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
AIP
AIP
ASMB
ASMB
Revenue
$20.1M
$10.8M
Net Profit
$-8.5M
$-9.2M
Gross Margin
90.8%
Operating Margin
-42.0%
-100.9%
Net Margin
-42.2%
-85.2%
Revenue YoY
30.0%
57.6%
Net Profit YoY
-3.7%
4.3%
EPS (diluted)
$-0.19
$-0.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIP
AIP
ASMB
ASMB
Q4 25
$20.1M
Q3 25
$17.4M
$10.8M
Q2 25
$16.5M
$9.6M
Q1 25
$16.5M
$9.4M
Q4 24
$15.5M
$7.4M
Q3 24
$14.7M
$6.8M
Q2 24
$14.6M
$8.5M
Q1 24
$12.9M
$5.8M
Net Profit
AIP
AIP
ASMB
ASMB
Q4 25
$-8.5M
Q3 25
$-9.0M
$-9.2M
Q2 25
$-9.1M
$-10.2M
Q1 25
$-8.1M
$-8.8M
Q4 24
$-8.2M
Q3 24
$-7.7M
$-9.6M
Q2 24
$-8.3M
$-11.2M
Q1 24
$-9.4M
$-9.1M
Gross Margin
AIP
AIP
ASMB
ASMB
Q4 25
90.8%
Q3 25
89.9%
Q2 25
89.4%
Q1 25
90.8%
Q4 24
89.8%
Q3 24
90.1%
Q2 24
90.0%
Q1 24
88.7%
Operating Margin
AIP
AIP
ASMB
ASMB
Q4 25
-42.0%
Q3 25
-50.1%
-100.9%
Q2 25
-50.0%
-115.2%
Q1 25
-46.6%
-105.5%
Q4 24
-45.9%
Q3 24
-53.8%
-160.1%
Q2 24
-51.1%
-143.0%
Q1 24
-70.5%
-185.5%
Net Margin
AIP
AIP
ASMB
ASMB
Q4 25
-42.2%
Q3 25
-51.6%
-85.2%
Q2 25
-55.3%
-105.9%
Q1 25
-49.1%
-93.6%
Q4 24
-53.0%
Q3 24
-52.2%
-140.4%
Q2 24
-57.2%
-130.7%
Q1 24
-72.6%
-156.9%
EPS (diluted)
AIP
AIP
ASMB
ASMB
Q4 25
$-0.19
Q3 25
$-0.21
$-0.72
Q2 25
$-0.22
$-1.33
Q1 25
$-0.20
$-1.17
Q4 24
$-0.19
Q3 24
$-0.20
$-1.51
Q2 24
$-0.22
$-1.98
Q1 24
$-0.25
$-1.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIP
AIP
ASMB
ASMB
Cash + ST InvestmentsLiquidity on hand
$33.9M
$22.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$-14.6M
$182.7M
Total Assets
$115.0M
$240.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIP
AIP
ASMB
ASMB
Q4 25
$33.9M
Q3 25
$39.0M
$22.5M
Q2 25
$38.0M
$24.0M
Q1 25
$42.3M
$23.4M
Q4 24
$43.8M
$38.3M
Q3 24
$48.7M
$28.5M
Q2 24
$45.8M
$19.2M
Q1 24
$44.8M
$18.7M
Stockholders' Equity
AIP
AIP
ASMB
ASMB
Q4 25
$-14.6M
Q3 25
$-11.4M
$182.7M
Q2 25
$-7.5M
$18.1M
Q1 25
$-4.8M
$27.1M
Q4 24
$-1.2M
$33.4M
Q3 24
$2.2M
$26.0M
Q2 24
$5.3M
$34.7M
Q1 24
$9.5M
$32.6M
Total Assets
AIP
AIP
ASMB
ASMB
Q4 25
$115.0M
Q3 25
$107.7M
$240.0M
Q2 25
$106.9M
$80.8M
Q1 25
$98.3M
$99.0M
Q4 24
$106.1M
$119.2M
Q3 24
$97.7M
$100.3M
Q2 24
$96.4M
$115.3M
Q1 24
$101.4M
$119.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIP
AIP
ASMB
ASMB
Operating Cash FlowLast quarter
$3.2M
$-15.1M
Free Cash FlowOCF − Capex
$3.0M
$-15.2M
FCF MarginFCF / Revenue
15.1%
-140.7%
Capex IntensityCapex / Revenue
0.7%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIP
AIP
ASMB
ASMB
Q4 25
$3.2M
Q3 25
$3.2M
$-15.1M
Q2 25
$-2.5M
$-16.8M
Q1 25
$2.9M
$-23.4M
Q4 24
$-2.6M
$-51.1M
Q3 24
$1.1M
$-15.2M
Q2 24
$311.0K
$-17.1M
Q1 24
$477.0K
$-18.4M
Free Cash Flow
AIP
AIP
ASMB
ASMB
Q4 25
$3.0M
Q3 25
$2.5M
$-15.2M
Q2 25
$-2.8M
Q1 25
$2.7M
Q4 24
$-2.7M
$-51.1M
Q3 24
$1.1M
Q2 24
$264.0K
$-17.1M
Q1 24
$281.0K
$-18.4M
FCF Margin
AIP
AIP
ASMB
ASMB
Q4 25
15.1%
Q3 25
14.2%
-140.7%
Q2 25
-17.2%
Q1 25
16.2%
Q4 24
-17.3%
-695.2%
Q3 24
7.4%
Q2 24
1.8%
-200.6%
Q1 24
2.2%
-317.7%
Capex Intensity
AIP
AIP
ASMB
ASMB
Q4 25
0.7%
Q3 25
4.1%
0.4%
Q2 25
2.2%
0.0%
Q1 25
1.1%
0.0%
Q4 24
0.3%
0.4%
Q3 24
0.2%
0.0%
Q2 24
0.3%
0.2%
Q1 24
1.5%
0.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIP
AIP

License And Maintenance$17.5M87%
Variable Royalties And Other$2.6M13%

ASMB
ASMB

Segment breakdown not available.

Related Comparisons